Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 ...

November 12, 2024 13:03 Stock market live today: Marksans Pharma Q2 net profit soars to ₹63.20 crore, shares rise 1.89% ...

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Indiamart Intermeshs subsidiary, Tradezeal Online entered into share purchase agreement to disinvest a 26% stake in Shipway Technology by way of sale of 4,088 Compulsorily Convertible Preference ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended ...

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

Reliance Power, Nykaa, 3M India, Sula Vineyards, BASF India, Natco Pharma, and Rattanindia Enterprises are among other firms ...

Marksans Pharma Ltd share price was down by -3.61% from the previous closing price of ₹299.40. Who are peers of Marksans Pharma Ltd? The peers of Marksans Pharma Ltd are Sun Pharmaceuticals ...

PrivateThe Q2 earnings season has crossed the peak and is now nearing the end of the season. Out of 4699 companies listed on exchanges, 1852 companies have already declared their quarterly financials ...

Belt Hold Bullish 1H 68 Oct 22, 2024 11:00PM ...